n-[4-(2-chloroacetyl)phenyl]-2,2-dimethylpropanamide, 97%, 100mg

4-((5-Bromopyridin-2-yl)methyl)morpholine, 95.0%, 5g

2-(Allyloxy)-1,2-oxaborolane, 97%, 1g

Ruthenium(IV) oxide, hydrate 10 g

1-Cyclohexyl-2-buten-1-ol, 90% tech, 5g

Methyl 2-(4-(tert-butyl)phenyl)-2-hydroxyacetate, 98%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(p-tolyl)propanoic acid, 95.0%, 100mg

3-Chloro-6-methoxypyridin-2(1H)-one, 98%, 1g

1-(6-Ethoxy-pyrimidin-4-yl)-piperidine-2-carboxylic acid, 95.0%, 100mg

1,3,5-Triazine>98.0%(GC)5g

Sample beakers with screw closure with graduation and labelling area, 120 ml, Sterile, 250 Piece(s)

4-NITROINDOLIN-2-ONE, 95.0%, 1g

(S)-tert-Butyl 4-(4-(4-(2-amino-3-methoxy-3-oxopropyl)phenoxy)butyl)piperidine-1-carboxylate, 97%, 250mg